1. Market Research
  2. > Healthcare Market Trends

Oncology Pathways in the US – Friend or Foe for Pharma?

  • July 2015
  • 59 pages
  • Datamonitor Healthcare
Report ID: 3384784

Summary

Table of Contents

Search Inside

The costs of treating cancer in the US are spiraling upward, and payers have taken notice. The growing focus on value and quality has driven greater use of clinical pathways: structured, standardized, evidence-based patient management plans that typically favor the most effective, least toxic, and lowest cost treatment options. Providers implement pathways to align treatment with best practices, and payers have used pathways in several models that tie incentives to oncologists’ adherence to on-pathway treatment.

Results from recent research with US payers suggest that the trend is toward a growing market for pathways, with a significant proportion of payers expecting the use of oncology pathway programs to increase. Given the potential of clinical pathways to open up markets to oncology medicines – or to erect significant barriers to their use – the pharmaceutical industry needs to carve out a more substantial role in the development or implementation of pathway-based payment programs, while bearing in mind that pathways are only one of the many tools that payers are using as they shift from paying for volume to reimbursing value.

This report addresses the following questions:
- Who is developing and using oncology clinical pathways?
- What is the role of oncology pathways in the evolving oncology cost management strategies?
- What impact have oncology pathways had on the oncology drug use so far?
- What are the drivers and resistors of wider use of oncology pathways from the perspective of different stakeholders?
- What key developments in the US reimbursement landscape are likely to influence the use of oncology pathways in the future and what will their impact will be?
- What strategies do pharmaceutical companies need to implement to mitigate the potential negative impact of oncology pathways on their oncology products or maximize opportunities?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2026

  • $ 10995
  • Industry report
  • June 2017
  • by GlobalData

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2026 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Physicians, Doctors And Other Healthcare Practitioners Market Global Report 2017

  • $ 6000
  • Industry report
  • July 2017
  • by The Business Research Company

Physicians are health practitioners having the degree of Doctor of Medicine (MD) or Doctor of Osteopathy (DO) primarily engaged in the independent practice of general or specialized medicine. Other health ...

Italy Neurology Devices Market Outlook to 2023 - CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment

  • $ 5995
  • Industry report
  • July 2017
  • by GlobalData

Italy Neurology Devices Market Outlook to 2023 - CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment Summary GlobalData’s ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.